Embed this press release by copying the code below:
NASDAQ: ACER Long Term Shareholder Notice: Investigation of Potential Wrongdoing at Acer Therapeutics Inc.
NASDAQ: ACER Long Term Shareholder Notice: Investigation of Potential Wrongdoing at Acer Therapeutics Inc.